MonaKotechaMD
Anesthesiology • Foster City, CAAssistant Professor, Anesthesiology, Geisel School of Medicine
Dr. Kotecha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Lakeside Dr
Foster City, CA 94404Phone+1 650-522-4065
Education & Training
University of California (San Francisco)Residency, Anesthesiology, 2005 - 2008
MedStar Health/Georgetown-Washington Hospital CenterInternship, Internal Medicine, 2004 - 2005
Yale School of MedicineClass of 2004
Certifications & Licensure
NH State Medical License 2012 - 2026
CA State Medical License 2006 - 2025- American Board of Anesthesiology Anesthesiology
Clinical Trials
- Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis Start of enrollment: 2016 Nov 14
- Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis Start of enrollment: 2017 Feb 23
Publications & Presentations
PubMed
- 12 citationsDesign of Phase 3 Studies Evaluating Vixotrigine for Treatment of Trigeminal NeuralgiaMona Kotecha, William P. Cheshire, Helen Finnigan, Kathryn Giblin, Himanshu Naik
Journal of Pain Research. 2020-07-01 - 7 citationsEfficacy and safety of vixotrigine in idiopathic or diabetes-associated painful small fibre neuropathy (CONVEY): a phase 2 placebo-controlled enriched-enrolment random...Catharina G Faber, Nadine Attal, Giuseppe Lauria, Robert H Dworkin, Roy Freeman
Eclinicalmedicine. 2023-05-01 - 17 citationsThe Relative Bioavailability and Effects of Food and Acid-Reducing Agents on Filgotinib Tablets in Healthy Subjects.Kacey Anderson, Hao Zheng, Mona Kotecha, Jennifer Cuvin, Bob Scott
Clinical Pharmacology in Drug Development. 2019-07-01
Press Mentions
New Antidepressants: Tackling Treatment Resistant DepressionMay 23rd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
